(Q33636580)

28 July 2017

1 reference

title

Immunomodulation: particular perspectives (English)

1 reference

28 July 2017

Borel JF

1

1 reference

28 July 2017

Hiestand PC

series ordinal

2

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

Transplantation Proceedings

28 July 2017

1 reference

28 July 2017

31

1 reference

28 July 2017

3

1 reference

28 July 2017

1464-1471

1 reference

28 July 2017

The wisdom of hindsight.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

Tolerance, danger, and the extended family

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

Will tolerance become a clinical reality?

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

Weaning of immunosuppression in long-term liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

New insights into mechanisms of allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

Immunosuppressive agents in clinical trials in transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

The pathophysiology of chronic rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

Chronic allograft failure: the clinical problem

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

Prolactin predicts cardiac allograft rejection in cyclosporin immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

Bromocriptine as an adjuvant to cyclosporine immunosuppression after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

Inhibition of chronic relapsing experimental allergic encephalomyelitis in the mouse by the alkyl-lysophospholipid ET-18-OCH3

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

SRI 62-834, a cyclic ether analogue of the phospholipid ET-18-OCH3, displays long-lasting beneficial effect in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Comparison with cyclosporin and (Val2)-dihydrocyclosporin effe

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

Immunomodulating activities of ethylene-2,2'-bis(dithio)bis(ethanol) and related compounds. Effects on murine lymphocyte proliferation and functions in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

Immunostimulatory properties of ethylene-2,2' -bis(dithio)bis(ethanol) and related compounds in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

In vivo pharmacological effects of ciclosporin and some analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2899%2900009-3

7 January 2021

10.1016/S0041-1345(99)00009-3

Identifiers

DOI

1 reference

release_ntscoj6w3rdjxhip7abpatog24

28 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ntscoj6w3rdjxhip7abpatog24

24 November 2022

mapped directly with Wikidata item

1 reference